Endothelial Progenitor Cells as Shuttle of Anticancer Agents-Reference-Cited by-同舟云学术

Endothelial Progenitor Cells as Shuttle of Anticancer Agents

Published:2016-10 Issue:10 Volume:27 Page:784-791
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Laurenzana Anna¹,Margheri Francesca¹,Chillà Anastasia¹,Biagioni Alessio¹,Margheri Giancarlo²,Calorini Lido¹³,Fibbi Gabriella¹,Del Rosso Mario¹³

Affiliation:

1. Department of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy

2. Institute for Complex Systems, National Research Council, Sesto Fiorentino, Italy

3. Center of Excellence for the Study at Molecular and Clinical Levels of Chronic, Degenerative, and Neoplastic Diseases to Develop Novel Therapies (DENOTHE), Florence, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2016.066

Reference55 articles.

1. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

2. Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors

3. Working hypothesis to redefine endothelial progenitor cells

4. Proangiogenic cells enhanced persistent and physiologic neovascularization compared with macrophages

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications;Cell Death & Disease;2023-09-04

2. Oncolytic virus: A catalyst for the treatment of gastric cancer;Frontiers in Oncology;2022-11-24

3. Harnessing nanotechnology for cardiovascular disease applications - a comprehensive review based on bibliometric analysis;Nano Today;2022-06

4. Increased number and function of endothelial progenitor cells in breast cancer patients and the linear correlation with VEGF level;Neoplasma;2022

5. Engineered microtissues for the bystander therapy against cancer;Materials Science and Engineering: C;2021-02